Sodium valproate stimulates potassium and chloride urinary excretion in rats: gender differences
- PMID: 17683602
- PMCID: PMC1959196
- DOI: 10.1186/1471-2210-7-9
Sodium valproate stimulates potassium and chloride urinary excretion in rats: gender differences
Abstract
Background: The diuretic effect of valproates and its relation to urinary potassium (K+) and chloride (Cl-) excretion have not yet been investigated, so the aim of this study was to evaluate the influence of a single dose of sodium valproate (NaVPA) on 24-h urinary K+ and Cl- excretion in young adult Wistar rats of both genders. For measurement of K+ in urine, the same animals and samples as in our earlier publication were used (Pharmacology 2005 Nov, 75:111-115). The authors propose a new approach to the pathophysiological mechanisms of NaVPA effect on K+ and Cl- metabolism. Twenty six Wistar rats were examined after a single intragastric administration of 300 mg/kg NaVPA (13 NaVPA-male and 13 NaVPA-female), 28 control intact Wistar rats (14 males and 14 females) were studied as a control group. The 24-h urinary K+, Cl-, creatinine and pH levels were measured.
Results: Total 24-h diuresis and 24-h diuresis per 100 g of body weight were found to be significantly higher in NaVPA-rats of both genders than in rats of the control group (p < 0.05). The data showed NaVPA to enhance 24-h K+ excretion in NaVPA-males and NaVPA-females with significant gender-related differences: 24-h K+ excretion in NaVPA-male rats was significantly higher than in control males (p = 0.003) and NaVPA-female rats (p < 0.001). Regarding the 24-h K+ excretion, NaVPA-female rats did not show a statistically significant difference versus females of the control group (p > 0.05). 24-h urinary K+ excretion per 100 g of body weight in NaVPA-male rats was significantly higher than in control males (p = 0.025). NaVPA enhanced Cl- urinary excretion: 24-h Cl- urinary excretion, 24-h urinary Cl- excretion per 100 g of body weight and the Cl-/creatinine ratio were significantly higher in NaVPA-male and NaVPA-female rats than in gender-matched controls (p < 0.05). 24-h chloriduretic response to NaVPA in male rats was significantly higher than in female rats (p < 0.05).
Conclusion: NaVPA causes kaliuretic and chloriduretic effects with gender-related differences in rats. Further investigations are necessary to elucidate the mechanism of such pharmacological effects of NaVPA.
Figures



Similar articles
-
Influence of sodium valproate on sodium and chloride urinary excretion in rats, gender differences.Pharmacology. 2005 Nov;75(3):111-5. doi: 10.1159/000087505. Epub 2005 Aug 15. Pharmacology. 2005. PMID: 16103742
-
Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats.Phytomedicine. 2005 May;12(5):363-9. doi: 10.1016/j.phymed.2003.12.010. Phytomedicine. 2005. PMID: 15957371
-
Cisplatin increases urinary sodium excretion in rats: gender-related differences.Medicina (Kaunas). 2010;46(1):45-50. Medicina (Kaunas). 2010. PMID: 20234163
-
Acute and chronic diuretic effect of ethanolic extract of leaves of Cocculus hirsutus (L.) Diles in normal rats.J Pharm Pharmacol. 2009 Mar;61(3):387-93. doi: 10.1211/jpp/61.03.0015. J Pharm Pharmacol. 2009. PMID: 19222913
-
[Pharmacological and toxicological properties of the saluretic xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)].Arzneimittelforschung. 1975 Feb;25(2):245-51. Arzneimittelforschung. 1975. PMID: 1173041 German.
Cited by
-
Simultaneous measurement of tadehaginoside and its principal metabolite in rats by HPLC-MS/MS and its application in pharmacokinetics and tissue distribution study.Pharm Biol. 2021 Dec;59(1):1415-1424. doi: 10.1080/13880209.2021.1990354. Pharm Biol. 2021. PMID: 34689683 Free PMC article.
-
Valproic Acid Inhibits NA-K-2CL Cotransporter RNA Expression in Male But Not in Female Rat Thymocytes.Dose Response. 2019 May 30;17(2):1559325819852444. doi: 10.1177/1559325819852444. eCollection 2019 Apr-Jun. Dose Response. 2019. PMID: 31210756 Free PMC article.
References
-
- Balding F, Jr, Geller HM. Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity. J Pharmacol Exp Ther. 1981;217:445–450. - PubMed
-
- Bureu M, Laschet J, Minier F, Chauvel P. Intervention of GABAergic neurotransmission in partial epilepsies. Rev Neurol. 1997;153:S46–S54. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical